Daewoong (003090) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Daewoong (003090) has a cash flow conversion efficiency ratio of 0.052x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩84.83 Billion ≈ $57.49 Million USD) by net assets (₩1.63 Trillion ≈ $1.10 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 003090 equity to assets ratio to measure how much of total assets are equity-financed.
Daewoong - Cash Flow Conversion Efficiency Trend (2001–2024)
This chart illustrates how Daewoong's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Daewoong (003090) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Daewoong Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Daewoong ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Immix Biopharma Inc
NASDAQ:IMMX
|
-0.116x |
|
Jiangxi Chen Guang New Materials Co Ltd
SHG:605399
|
-0.014x |
|
Ram Ratna Wires Limited
NSE:RAMRAT
|
0.019x |
|
Fireweed Zinc Ltd
V:FWZ
|
-0.677x |
|
QUADIENT SA ADR1/15/EO 1
F:NEQ0
|
N/A |
|
Dareway Software Co Ltd
SHG:688579
|
0.006x |
|
Deutsche Pfandbriefbank AG
XETRA:PBB
|
0.009x |
|
Tatva Chintan Pharma Chem Limited
NSE:TATVA
|
0.017x |
Annual Cash Flow Conversion Efficiency for Daewoong (2001–2024)
The table below shows the annual cash flow conversion efficiency of Daewoong from 2001 to 2024. For the full company profile with market capitalisation and key ratios, see Daewoong (003090) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩1.50 Trillion ≈ $1.02 Billion |
₩162.38 Billion ≈ $110.05 Million |
0.108x | -24.49% |
| 2023-12-31 | ₩1.44 Trillion ≈ $973.70 Million |
₩205.65 Billion ≈ $139.37 Million |
0.143x | +22.84% |
| 2022-12-31 | ₩1.28 Trillion ≈ $867.10 Million |
₩149.08 Billion ≈ $101.03 Million |
0.117x | +1.23% |
| 2021-12-31 | ₩1.16 Trillion ≈ $784.11 Million |
₩133.18 Billion ≈ $90.25 Million |
0.115x | -11.56% |
| 2020-12-31 | ₩1.12 Trillion ≈ $756.92 Million |
₩145.37 Billion ≈ $98.51 Million |
0.130x | -3.57% |
| 2019-12-31 | ₩1.03 Trillion ≈ $695.47 Million |
₩138.51 Billion ≈ $93.87 Million |
0.135x | +186.80% |
| 2018-12-31 | ₩964.31 Billion ≈ $653.50 Million |
₩45.38 Billion ≈ $30.75 Million |
0.047x | -70.09% |
| 2017-12-31 | ₩939.31 Billion ≈ $636.55 Million |
₩147.77 Billion ≈ $100.14 Million |
0.157x | +625.25% |
| 2016-12-31 | ₩864.63 Billion ≈ $585.95 Million |
₩18.76 Billion ≈ $12.71 Million |
0.022x | -76.01% |
| 2015-12-31 | ₩828.48 Billion ≈ $561.45 Million |
₩74.92 Billion ≈ $50.77 Million |
0.090x | +37.51% |
| 2014-12-31 | ₩708.73 Billion ≈ $480.30 Million |
₩46.61 Billion ≈ $31.59 Million |
0.066x | -47.58% |
| 2013-12-31 | ₩687.07 Billion ≈ $465.62 Million |
₩86.19 Billion ≈ $58.41 Million |
0.125x | +77.80% |
| 2012-12-31 | ₩391.40 Billion ≈ $265.24 Million |
₩27.62 Billion ≈ $18.71 Million |
0.071x | +127.92% |
| 2011-12-31 | ₩336.10 Billion ≈ $227.77 Million |
₩10.40 Billion ≈ $7.05 Million |
0.031x | -56.40% |
| 2010-12-31 | ₩484.70 Billion ≈ $328.47 Million |
₩34.42 Billion ≈ $23.32 Million |
0.071x | -74.17% |
| 2009-12-31 | ₩429.38 Billion ≈ $290.98 Million |
₩118.04 Billion ≈ $79.99 Million |
0.275x | +99.96% |
| 2008-12-31 | ₩412.53 Billion ≈ $279.57 Million |
₩56.71 Billion ≈ $38.43 Million |
0.137x | +19.93% |
| 2007-12-31 | ₩363.46 Billion ≈ $246.31 Million |
₩41.66 Billion ≈ $28.23 Million |
0.115x | -35.45% |
| 2006-12-31 | ₩294.16 Billion ≈ $199.35 Million |
₩52.24 Billion ≈ $35.40 Million |
0.178x | +16.42% |
| 2005-12-31 | ₩251.13 Billion ≈ $170.19 Million |
₩38.30 Billion ≈ $25.96 Million |
0.153x | -3.90% |
| 2004-12-31 | ₩222.67 Billion ≈ $150.90 Million |
₩35.34 Billion ≈ $23.95 Million |
0.159x | +3.01% |
| 2003-12-31 | ₩213.98 Billion ≈ $145.01 Million |
₩32.97 Billion ≈ $22.34 Million |
0.154x | -1.38% |
| 2002-12-31 | ₩205.55 Billion ≈ $139.30 Million |
₩32.11 Billion ≈ $21.76 Million |
0.156x | -43.51% |
| 2001-12-31 | ₩228.75 Billion ≈ $155.02 Million |
₩63.26 Billion ≈ $42.87 Million |
0.277x | -- |
About Daewoong
Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Phar… Read more